Rare Disease AdvisorMuscle Ultrasound Can Detect Myasthenia Gravis Based on Fatigability

⚠️ Small Study / Early Comparative Evidence

This single-center case-control study evaluated whether muscle ultrasound could identify generalized myasthenia gravis (MG) through exercise-induced fatigability rather than static muscle measurements. Investigators assessed 35 patients with generalized MG and 35 matched healthy controls using ultrasound examinations before and after a standardized exercise protocol. Baseline muscle thickness, echogenicity, and area were not discriminatory, whereas post-exercise changes in muscle area differentiated patients from controls. The findings represent early diagnostic evidence and require external validation before broader clinical adoption.

Clinical Considerations

• Fatigability-related changes in muscle area consistently distinguished generalized MG from healthy controls.
• Baseline ultrasound measures, including muscle thickness, echogenicity, and area, did not differ between groups.
• Post-exercise weakness was most prominent in the rectus femoris and tibialis anterior muscles.
• Composite measures from four muscles correctly classified 86.5% to 87.2% of participants, with overall accuracy approaching 90%.
• Diagnostic performance remained relatively stable across disease-severity groups and differing cumulative corticosteroid exposure.
• Important limitations included single-center enrollment, nonblinded image acquisition, a single operator, lack of reliability testing, and no assessment of ocular, facial, or bulbar muscles.

Practice Applications

• Recognize that exercise-induced ultrasound changes may provide a functional assessment of neuromuscular fatigability.
• Interpret these findings as preliminary diagnostic evidence rather than a substitute for established MG testing.
• Consider muscle ultrasound as an emerging adjunctive assessment tool pending independent validation.
• Avoid overinterpreting reported classification accuracy until multicenter studies confirm reproducibility.
• Monitor future studies evaluating clinically relevant muscle groups frequently affected in early MG.